AI Verdict
RIGL has stronger fundamentals based on our AI analysis.
RILYT vs RIGL Fundamental Comparison
| Metric | RILYT | RIGL |
|---|---|---|
| Revenue | $967.6M | $294.3M |
| Net Income | $307.4M | $367.0M |
| Net Margin | 31.8% | 124.7% |
| ROE | N/A | 93.8% |
| ROA | 18.0% | 71.5% |
| Current Ratio | 2.24x | 2.42x |
| Debt/Equity | N/A | 0.13x |
| EPS | $9.80 | $19.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RILYT vs RIGL: Frequently Asked Questions
Is RILYT or RIGL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RIGL has stronger fundamentals. RILYT is rated STRONG SELL (88% confidence) while RIGL is rated HOLD (68% confidence). This is not investment advice.
How does RILYT compare to RIGL fundamentally?
BRC Group Holdings, Inc. has ROE of N/A vs RIGEL PHARMACEUTICALS INC's 93.8%. Net margins are 31.8% vs 124.7% respectively.
Which stock pays higher dividends, RILYT or RIGL?
RILYT has a dividend yield of N/A or no dividend while RIGL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RILYT or RIGL for long term?
For long-term investing, consider that RILYT has STRONG SELL rating with 88% confidence, while RIGL has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RILYT vs RIGL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RILYT vs RIGL, the AI consensus favors RIGL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.